The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 20, 2024
Filed:
Jan. 22, 2021
Applicant:
Spiral Therapeutics Inc., Brisbane, CA (US);
Inventors:
Eugene de Juan, Brisbane, CA (US);
Hugo Peris, Brisbane, CA (US);
Signe Erickson, Brisbane, CA (US);
Vrad Levering, Brisbane, CA (US);
Assignee:
Spiral Therapeutics Inc., South San Francisco, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61B 1/227 (2006.01); A61B 1/018 (2006.01); G02B 21/00 (2006.01); G02B 21/22 (2006.01); A61B 17/29 (2006.01); A61M 31/00 (2006.01); A61B 17/34 (2006.01); A61M 37/00 (2006.01); A61B 17/32 (2006.01); A61B 18/04 (2006.01); A61B 18/20 (2006.01); A61F 2/958 (2013.01); A61B 17/3205 (2006.01); A61B 18/14 (2006.01); A61F 11/20 (2022.01); A61B 17/00 (2006.01); A61B 18/00 (2006.01); A61F 2/18 (2006.01);
U.S. Cl.
CPC ...
G02B 21/0012 (2013.01); A61B 1/018 (2013.01); A61B 1/227 (2013.01); A61B 17/29 (2013.01); A61B 17/3205 (2013.01); A61B 17/320068 (2013.01); A61B 17/3423 (2013.01); A61B 17/3468 (2013.01); A61B 17/3478 (2013.01); A61B 18/04 (2013.01); A61B 18/1485 (2013.01); A61B 18/20 (2013.01); A61F 2/958 (2013.01); A61F 11/20 (2022.01); A61F 11/202 (2022.01); A61M 31/00 (2013.01); A61M 31/002 (2013.01); A61M 37/0015 (2013.01); G02B 21/0032 (2013.01); G02B 21/22 (2013.01); A61B 2017/00115 (2013.01); A61B 2017/00787 (2013.01); A61B 2017/00867 (2013.01); A61B 2017/32007 (2017.08); A61B 2018/00327 (2013.01); A61B 2217/005 (2013.01); A61F 2002/183 (2013.01); A61F 2250/0067 (2013.01); A61M 2037/0023 (2013.01); A61M 2037/0046 (2013.01); A61M 2205/04 (2013.01); A61M 2210/0662 (2013.01); A61M 2210/0668 (2013.01);
Abstract
Systems and methods can be employed for trans-tympanic membrane access to the middle ear for delivery of a formulation or implant device to a target location under direct visualization. The systems and methods can also be used to improve accessibility and visualization for various otological surgical procedures, such as, but not limited to, cholesteatoma removal, tympanic membrane repair and ossicular chain repair.